Asian Stocks Gain on China Recovery, Weaker Dollar: Markets Wrap

Asian Stocks Gain on China Recovery, Weaker Dollar: Markets Wrap

A decline in the dollar and indications of economic stabilization in China helped Asian stocks rise. Australia’s and Hong Kong’s stocks rose after statistics revealed that China’s retail sales growth was the largest in eight months. Because of the yen’s depreciation, Japanese benchmarks increased by almost 0.8%. US contracts declined. A five-day increase that was

Asian Stocks Gain on China Recovery, Weaker Dollar: Markets Wrap Read More »

Q2 Results Review: 66% companies see EPS cut, small and midcaps hit hard

Q2 Results Review: 66% companies see EPS cut, small and midcaps hit hard

Muted sales growth and a drop in profits and margins have been the hallmarks of the second quarter of FY25’s disappointing corporate earnings. Notwithstanding the respectable performance of the Banking, Financial Services, and Insurance (BFSI) industry, non-financial businesses nonetheless confront formidable obstacles. 45% of the 227 companies in the 275-stock JM Financial coverage area have

Q2 Results Review: 66% companies see EPS cut, small and midcaps hit hard Read More »

Japan's Nikkei rises as auto, bank shares gain: All You Need To Know

Japan’s Nikkei rises as auto, bank shares gain: All You Need To Know

As a weaker yen helped manufacturers and financial sectors rise after increasing their yearly profit projections, Japan’s Nikkei share average increased on Friday. The Nikkei is expected to lose 2.4% for the week, despite being up 0.8% at 38,842.13 during the lunch break. Although the overall Topix has increased by 0.86% to 2,724.35, it is

Japan’s Nikkei rises as auto, bank shares gain: All You Need To Know Read More »

JB Pharma, Sun, Torrent ,Lupin, Abbott lead pharma market growth : Know More Here

JB Pharma, Sun, Torrent ,Lupin, Abbott lead pharma market growth : Know More Here

In November, the Nifty Pharma index had a 4% drop. Even though it started on a high base, the growth of the Indian pharmaceutical industry in October was not particularly encouraging, and the selling pressure in the domestic markets is what caused this fall. According to reports, the growth of the pharmaceutical market in October

JB Pharma, Sun, Torrent ,Lupin, Abbott lead pharma market growth : Know More Here Read More »

Mankind Pharma pledges 39.68% stake in Bharat Serums to secure ₹5,000 crore NCDs

Mankind Pharma pledges 39.68% stake in Bharat Serums to secure ₹5,000 crore NCDs

Bharat Serums and Vaccines Limited (BSV), a fully-owned subsidiary of Mankind Pharma Limited, has pledged 39.68 per cent of its equity stake to secure non-convertible debentures (NCDs) worth ₹5,000 crores. As the common security trustee for these NCDs, Catalyst Trusteeship Limited was designated by SEBI’s Listing Obligations and Disclosure Requirements Regulations, 2015. The share price

Mankind Pharma pledges 39.68% stake in Bharat Serums to secure ₹5,000 crore NCDs Read More »

Eicher Motors shares rally 8% after steady Q2 earnings. What analysts say

Eicher Motors shares rally 8% after steady Q2 earnings. What analysts say

In early morning trading on Thursday, November 14, shares of Eicher Motors, the world leader in the middleweight motorbike market, jumped by about 8% to ₹4,940 per share after the firm reported a higher-than-expected quarterly profit on Wednesday. Strong sales of higher-margin motorcycles with engine displacements greater than 350 cc propelled the rhythm. Despite fierce

Eicher Motors shares rally 8% after steady Q2 earnings. What analysts say Read More »

NALCO shares rally 5% after Q2 profit rises multi-fold to Rs 1,046 crore

NALCO shares rally 5% after Q2 profit rises multi-fold to Rs 1,046 crore

On Wednesday, state-owned Nalco said that because of increased operating income, its consolidated profit increased more than fivefold to Rs 1,045.97 crore for the quarter that ended in September 2024. During the previous year, National Aluminium Company Ltd. (Nalco) reported a consolidated profit of Rs 187.35 crore, according to a stock exchange filing. The latest

NALCO shares rally 5% after Q2 profit rises multi-fold to Rs 1,046 crore Read More »

Niva Bupa shares list at ₹78.14 on NSE, up 5.5% from IPO price

Niva Bupa shares list at ₹78.14 on NSE, up 5.5% from IPO price

On Thursday, November 14, Niva Bupa Health Insurance shares made a respectable market debut, listing at ₹78.14 on the NSE, 5.5 per cent above the issue price of ₹74. It listed at ₹78.5 on the BSE, up 6.08 per cent from the IPO price. Subscriptions for Niva Bupa’s ₹2,200 crore initial public offering (IPO) were

Niva Bupa shares list at ₹78.14 on NSE, up 5.5% from IPO price Read More »